Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-dose-rate intracavitary brachytherapy combined with external beam radiotherapy for stage IIIb adenocarcinoma of the uterine cervix in Japan: a multi-institutional study of Japanese Society of Therapeutic Radiology and Oncology 2006-2007 (study of JASTRO 2006-2007).
Niibe Y, Kenjo M, Onishi H, Ogawa Y, Kazumoto T, Ogino I, Tsujino K, Harima Y, Takahashi T, Anbai A, Tsuchida E, Toita T, Takemoto M, Yamashita H, Hayakawa K. Niibe Y, et al. Jpn J Clin Oncol. 2010 Aug;40(8):795-9. doi: 10.1093/jjco/hyq053. Epub 2010 May 5. Jpn J Clin Oncol. 2010. PMID: 20444747
Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: a multi-institutional study.
Niibe Y, Kazumoto T, Toita T, Yamazaki H, Higuchi K, Ii N, Suzuki K, Uno T, Tokumaru S, Takayama M, Sekiguchi K, Matsumoto Y, Michimoto K, Oguchi M, Hayakawa K. Niibe Y, et al. Gynecol Oncol. 2006 Nov;103(2):435-8. doi: 10.1016/j.ygyno.2006.03.034. Epub 2006 May 4. Gynecol Oncol. 2006. PMID: 16677691
Multi-institutional study of radiation therapy for isolated para-aortic lymph node recurrence in uterine cervical carcinoma: 84 subjects of a population of more than 5,000.
Niibe Y, Kenjo M, Kazumoto T, Michimoto K, Takayama M, Yamauchi C, Kataoka M, Suzuki K, Ii N, Uno T, Takanaka T, Higuchi K, Yamazaki H, Tokumaru S, Oguchi M, Hayakawa K; Japanease Isolated Para-Aortic Lymph Node Recurrence of Uterine Cervical Carcinoma Study Group. Niibe Y, et al. Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1366-9. doi: 10.1016/j.ijrobp.2006.07.1384. Int J Radiat Oncol Biol Phys. 2006. PMID: 17126206
Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma: Kitasato Gynecologic Radiation Oncology Group (KGROG 0501).
Niibe Y, Hayakawa K, Tsunoda S, Kanai T, Imai M, Arai M, Arai T, Kawaguchi M, Jobo T, Hamada Y, Yago K, Unno N; Kitasato Gynecologic Radiation Oncology Group. Niibe Y, et al. Jpn J Clin Oncol. 2007 Jan;37(1):70-2. doi: 10.1093/jjco/hyl153. Epub 2007 Jan 4. Jpn J Clin Oncol. 2007. PMID: 17204507 Clinical Trial.
Quality assurance in the prospective multi-institutional trial on definitive radiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer: the individual case review.
Toita T, Oguchi M, Ohno T, Kato S, Niibe Y, Kodaira T, Kazumoto T, Kataoka M, Shikama N, Kenjo M, Teshima T, Kagami Y. Toita T, et al. Among authors: niibe y. Jpn J Clin Oncol. 2009 Dec;39(12):813-9. doi: 10.1093/jjco/hyp105. Epub 2009 Oct 7. Jpn J Clin Oncol. 2009. PMID: 19815538
Radiotherapy quality assurance of the Japanese Gynecologic Oncology Group study (JGOG1066): a cooperative phase II study of concurrent chemoradiotherapy for uterine cervical cancer.
Toita T, Kato S, Ishikura S, Tsujino K, Kodaira T, Uno T, Hatano K, Sakurai H, Niibe Y, Kazumoto T, Nishimura T, Kitagawa R, Fukutani M, Oguchi M, Umayahara K, Hirashima Y, Aoki Y, Takizawa K; Disease Committee of Radiation Oncology, Japanese Gynecologic Oncology Group. Toita T, et al. Among authors: niibe y. Int J Clin Oncol. 2011 Aug;16(4):379-86. doi: 10.1007/s10147-011-0196-4. Epub 2011 Feb 18. Int J Clin Oncol. 2011. PMID: 21331768
Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
Toita T, Kato S, Niibe Y, Ohno T, Kazumoto T, Kodaira T, Kataoka M, Shikama N, Kenjo M, Tokumaru S, Yamauchi C, Suzuki O, Sakurai H, Numasaki H, Teshima T, Oguchi M, Kagami Y, Nakano T, Hiraoka M, Mitsuhashi N. Toita T, et al. Among authors: niibe y. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):e49-56. doi: 10.1016/j.ijrobp.2011.01.022. Epub 2011 Apr 4. Int J Radiat Oncol Biol Phys. 2012. PMID: 21470794
High-dose-rate intra-cavitary brachytherapy combined with external beam radiation therapy for under 40-year-old patients with invasive uterine cervical carcinoma: clinical outcomes in 118 Patients in a Japanese multi-institutional study, JASTRO.
Yamashita H, Niibe Y, Toita T, Kazumoto T, Nishimura T, Kodaira T, Eto H, Kinoshita R, Tsujino K, Onishi H, Takemoto M, Hayakawa K. Yamashita H, et al. Among authors: niibe y. Jpn J Clin Oncol. 2013 May;43(5):547-52. doi: 10.1093/jjco/hyt029. Epub 2013 Mar 8. Jpn J Clin Oncol. 2013. PMID: 23475536
75 results